Skip to main content
logo
Balaxi Pharmaceuticals Limited (NSE:BALAXI)
India flag India · Delayed Price · Currency is INR
18.65
-1.38 (-6.89%)
At close: Mar 13, 2026

Balaxi Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
1,0303,2545,0495,3873,5165,245
Market Cap Growth
-62.50%-35.56%-6.27%53.22%-32.97%608.78%
Enterprise Value
1,2062,9664,9555,3053,4915,213
Last Close Price
18.6563.9299.19106.0770.23104.76
PE Ratio
10.6812.98-11.727.3813.75
PS Ratio
0.371.112.091.601.262.27
PB Ratio
0.431.402.512.953.118.07
P/TBV Ratio
0.501.592.883.423.918.23
P/FCF Ratio
--120.99-12.20-
P/OCF Ratio
--103.7788.6710.30169193.55
EV/Sales Ratio
0.441.012.051.581.252.25
EV/EBITDA Ratio
5.868.0110.609.386.9512.24
EV/EBIT Ratio
6.358.4011.109.687.0212.33
EV/FCF Ratio
--118.73-12.11-
Debt / Equity Ratio
0.240.230.100.070.030.06
Debt / EBITDA Ratio
2.741.440.420.240.070.09
Debt / FCF Ratio
--4.65-0.13-
Net Debt / Equity Ratio
0.070.06-0.21-0.08-0.030.03
Net Debt / EBITDA Ratio
0.870.34-0.92-0.27-0.070.05
Net Debt / FCF Ratio
--0.23-10.342.17-0.13-1.56
Asset Turnover
-1.030.971.622.023.41
Inventory Turnover
-2.071.382.033.5323.92
Quick Ratio
-2.812.211.540.582.28
Current Ratio
-4.453.883.642.232.70
Return on Equity (ROE)
-11.58%-1.24%31.05%53.51%82.26%
Return on Assets (ROA)
-7.76%11.21%16.46%22.51%38.97%
Return on Invested Capital (ROIC)
5.17%15.34%-32.45%31.94%49.28%77.10%
Return on Capital Employed (ROCE)
-13.80%21.90%29.40%43.90%65.10%
Earnings Yield
9.17%7.70%-0.47%8.53%13.55%7.27%
FCF Yield
--17.25%0.83%-1.30%8.20%-0.24%
Dividend Yield
----0.14%-
Payout Ratio
---1.08%--
Buyback Yield / Dilution
0.91%-7.26%-1.69%-1.23%--32.96%
Total Shareholder Return
0.91%-7.26%-1.69%-1.23%0.14%-32.96%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.